Koppel Adam (CIK 0001578965)

Latest company ownership

Shares held
4,034,582
Last filed at
Jan 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4
Shares held
2,338,968
Last filed at
Jul 26, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
1,334,562
Last filed at
Jul 21, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
859,573
Last filed at
Feb 6, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
ANNX - Annexon, Inc.
Role: 10% Owner
Shares held
319,243
Last filed at
Jul 28, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
BIIB - BIOGEN INC.
Role: EVP, Strategy and Bus. Dev.
Shares held
2,402.11
Last filed at
Jun 7, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 19, 2021 Jul 21, 2021 RAPID MICRO BIOSYSTEMS, INC. 10% Owner Buy 87.5 +100,000 1.20% ✗ $2M
Jul 28, 2020 Jul 28, 2020 Annexon, Inc. 10% Owner Buy 100.0 +400,000 14.08% ✗ $6.8M
Feb 4, 2020 Feb 6, 2020 Arcutis Biotherapeutics, Inc. 10% Owner Buy 95.0 +294,117 7.98% ✗ $5M
Jul 24, 2018 Jul 26, 2018 Replimune Group, Inc. Director Buy 100.0 +500,000 21.38% ✗ $7.5M
Jan 25, 2018 Feb 1, 2018 Solid Biosciences Inc. Director Buy 100.0 +300,000 17.76% ✗ $4.8M
Jun 6, 2016 Jun 7, 2016 BIOGEN INC. EVP, Strategy and Bus. Dev. Sell 20.0 -555 -18.77% ✓ $161K
Jun 2, 2016 Jun 6, 2016 BIOGEN INC. EVP, Strategy and Bus. Dev. Sell 22.5 -534 -15.30% ✗ $154.7K
Apr 6, 2016 Apr 7, 2016 BIOGEN INC. EVP, Strategy and Bus. Dev. Sell 36.3 -102 -5.23% ✓ $28.1K
Feb 23, 2016 Feb 25, 2016 BIOGEN INC. EVP, Strategy and Bus. Dev. Sell 26.3 -98 -4.99% ✗ $25.4K
Jun 2, 2015 Jun 4, 2015 BIOGEN INC. SVP, Chief Strategy Officer Sell 20.0 -852 -33.89% ✗ $330.3K